Increased metastasis with loss of E2F2 in Myc-driven tumors
收藏官方服务：
资源简介：
Increased metastasis with loss of E2F2 in Myc-driven tumors
应用场景：
创建时间：
2016-08-08
相关数据集
Additional file 1 of High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer
Additional file 1: Figure S1. Clinical and pathological characteristics of 202 breast cancer patients. Figure S2. Correlation between B3GATL5 expression levels and stage or grade of breast cancers. Tu
NIAID Data Ecosystem60
Global gene expression profiling of primary tumors and lung metastases using a mouse model of spontaneous metastatic mammary carcinoma. Mus musculus
In this study, we explored the molecular basis of site-specific metastasis of breast cancer to the lungs in a clinically relevant model based on the JygMC(A) cell line. In this dataset, we include exp
NIAID Data Ecosystem60
DataSheet_1_Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets.zip
Colorectal cancer (CRC) is one of the major causes of cancer deaths across the world. Patients’ survival at time of diagnosis depends mainly on stage of the tumor. Therefore, understanding the molecul
NIAID Data Ecosystem40
CC family Cytokines and Receptors deleted in primary but not metastatic tumors.
Chr: chromosome, seg start/end: segment start and end.
NIAID Data Ecosystem60
MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [RNA-seq MDA231 KO vs WT]. MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial-Mesenchymal Transition State [RNA-seq MDA231 KO vs WT]
Loss of MLL3 facilitates mesenchymal cells to acquire a mesenchymal/epithelial hybrid state during metastatic colonization. MLL3 loss led to IFNg signaling upregulation, which contributes to the induc
NIAID Data Ecosystem50
